These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 19591040)

  • 1. Antigenicity of a type A influenza virus through comparison of hemagglutination inhibition and mass spectrometry immunoassays.
    Schwahn AB; Downard KM
    J Immunoassay Immunochem; 2009; 30(3):245-61. PubMed ID: 19591040
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antigenic characterisation of H3N2 subtypes of the influenza virus by mass spectrometry.
    Morrissey B; Streamer M; Downard KM
    J Virol Methods; 2007 Nov; 145(2):106-14. PubMed ID: 17588679
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kinetics of antigen-antibody interactions employing a MALDI mass spectrometry immunoassay.
    Morrissey B; Downard KM
    Anal Chem; 2008 Oct; 80(20):7720-6. PubMed ID: 18816071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A proteomics approach to survey the antigenicity of the influenza virus by mass spectrometry.
    Morrissey B; Downard KM
    Proteomics; 2006 Apr; 6(7):2034-41. PubMed ID: 16502471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antigenic analysis of recent H1N1 influenza viruses with monoclonal antibodies.
    Yamada A; Cao MS; Imanishi J; Oyama S; Abe A; Katagiri S
    Acta Virol; 1991 Aug; 35(4):343-9. PubMed ID: 1724874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monoclonal antibodies to the haemagglutinin HA1 subunit of the pandemic influenza A/H1N1 2009 virus and potential application to serodiagnosis.
    Samuel D; Warrener L; Hoschler K
    J Med Virol; 2011 Apr; 83(4):559-67. PubMed ID: 21328368
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antigenic surveillance of the influenza virus by mass spectrometry.
    Kiselar JG; Downard KM
    Biochemistry; 1999 Oct; 38(43):14185-91. PubMed ID: 10571992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Peptide mapping of the monoclonal antibodies against the heavy chain hemagglutinin from influenza virus H3N2].
    Mazurkova NA; Isaeva EI; Podcherniaeva RIa
    Mol Gen Mikrobiol Virusol; 2006; (4):19-23. PubMed ID: 17094654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Highly conserved sequences for human neutralization epitope on hemagglutinin of influenza A viruses H3N2, H1N1 and H5N1: Implication for human monoclonal antibody recognition.
    Yamashita A; Kawashita N; Kubota-Koketsu R; Inoue Y; Watanabe Y; Ibrahim MS; Ideno S; Yunoki M; Okuno Y; Takagi T; Yasunaga T; Ikuta K
    Biochem Biophys Res Commun; 2010 Mar; 393(4):614-8. PubMed ID: 20152806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of twenty rapid antigen tests for the detection of human influenza A H5N1, H3N2, H1N1, and B viruses.
    Taylor J; McPhie K; Druce J; Birch C; Dwyer DE
    J Med Virol; 2009 Nov; 81(11):1918-22. PubMed ID: 19774693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Divergent genetic evolution of hemagglutinin in influenza A H1N1 and A H1N2 subtypes isolated in the south-France since the winter of 2001-2002.
    Al Faress S; Cartet G; Ferraris O; Norder H; Valette M; Lina B
    J Clin Virol; 2005 Jul; 33(3):230-6. PubMed ID: 15911445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Eurocine L3 adjuvants with subunit influenza antigens induce protective immunity in mice after intranasal vaccination.
    Petersson P; Hedenskog M; Alves D; Brytting M; Schröder U; Linde A; Lundkvist A
    Vaccine; 2010 Sep; 28(39):6491-7. PubMed ID: 20637767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of influenza virus haemolytic and haemagglutination activities by monoclonal antibodies to haemagglutinin glycopolypeptides HA1 and HA2.
    Kostolanský F; Styk B; Russ G
    Acta Virol; 1989 Dec; 33(6):504-12. PubMed ID: 2576592
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Antigenic and genetic study of influenza virus circulated in China in 2006].
    Zhang Y; Zhao X; Guo JF; Wei HJ; Cheng YH; Li XW; Xu CL; Guo YJ; Shu YL
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2007 Dec; 21(4):304-6. PubMed ID: 18322584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An alternative method for preparation of pandemic influenza strain-specific antibody for vaccine potency determination.
    Schmeisser F; Vodeiko GM; Lugovtsev VY; Stout RR; Weir JP
    Vaccine; 2010 Mar; 28(12):2442-9. PubMed ID: 20074687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Preparation of monoclonal antibodies against HA protein of subtype H1 of swine influenza virus].
    Li HT; Liu M; Liu CG; Du JL
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2009 Mar; 25(3):233-5. PubMed ID: 19257989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of cross-reactive antibodies against mimotopes of H5N1 hemagglutinin.
    Song H; Luo W; Chen Y; Du H; Tang J; Yin B; Chen Y; Shih JW; Zhang J
    Vet Microbiol; 2010 Sep; 145(1-2):17-22. PubMed ID: 20338700
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rapid differentiation of seasonal and pandemic H1N1 influenza through proteotyping of viral neuraminidase with mass spectrometry.
    Schwahn AB; Wong JW; Downard KM
    Anal Chem; 2010 Jun; 82(11):4584-90. PubMed ID: 20443622
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monoclonal antibodies to glycopolypeptides HA1 and HA2 of influenza virus haemagglutinin.
    Russ G; Poláková K; Kostolanský F; Styk B; Vancíková M
    Acta Virol; 1987 Sep; 31(5):374-86. PubMed ID: 2891276
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influenza vaccine immunogenicity in 6- to 23-month-old children: are identical antigens necessary for priming?
    Walter EB; Neuzil KM; Zhu Y; Fairchok MP; Gagliano ME; Monto AS; Englund JA
    Pediatrics; 2006 Sep; 118(3):e570-8. PubMed ID: 16950948
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.